Eclampsia is one of the most sever , life - threatening diseases occurred in pregnancy, MgSO4 is the best drug used for its treatment. In this study, the comparison between shortened regimen of MgSO4 versus standard Zuspan course in controlling eclampsia was done. This study performed along one year (July 2019-July 2020) at El Shatby Maternity University Hospital, 40 eclamptic patients presenting at the emergency unit were randomized. Group A received the standard Zuspan regimen of magnesium sulphate and group B received short course in which the patients received only two doses of intravenous magnesium sulphate four hours apart postpartal. Results: The maternal outcomes regarding recurrence of the fits were compared. The maternal complications and postpartal fits were the same in both groups. The dose of MgSO4 in the shortened group was decreased by 40% in 42.5% of the cases. Conclusions: The shortened course of MgSO4 postpartal is the same as the standard regimen in the controlling eclampsia.
Eclampsia is known as grand mal seizure activity newly happened during pregnancy or postpartally in pregnant women known with preeclampsia during pregnancy [
Eclampsia is a strong cause of maternal deaths worldwide. Eclampsia is associated with approximately 13% of maternal deaths worldwide [
MgSO4 is the best drug used for reducing the incidence of eclampsia intrapartum and/or postpartum [
MgSO4 is the drug that the World Health Organization is recommending as the most effective, available and safe anticonvulsant treatment for severe pre-eclampsia and eclampsia [
There are two main courses available for MgSO4 treatment:
1) In the Pritchard Regimen, 4 g of MgSO4 is the starting loading dose, given slowly over 5 - 10 minutes intravenously followed by 10 g intramuscularly (5 g in each gluteal muscle). Subsequently, then every 4 hours, 5 g is given intramuscularly into alternate gluteal muscle [
2) In the Zuspan regimen,4 g is given slowly as the loading dose intravenously slowly over 5 - 10 min followed by 1 - 2 g infusion, the maintenance dose, every hour by an infusion pump [
About 40% of serum MgSO4 is bound to protein after its administration. The unbound MgSO4 ion diffuses into the different body tissue [
The clinical and toxicity effect of magnesium sulphate is correlated to its plasma concentration. 1.8 to 3.0 mmol/L plasma level of MgSO4 is the proper treatment of eclamptic fits. The dose of MgSO4 and its serum concentration for prophylaxis is not estimated [
The warning sign of impending MgSO4 toxicity in the mother firstly is loss of the patellar reflex with MgSO4 serum level between 3.5 and 5 mmol/L [
Magnesium sulphate toxicity is rare specially with close monitoring during treatment, but reducing the amount and duration of its treatment to reduce its adverse effects and reduce patient discomfort was the main concern of many researches [
In this study, comparison between the effectiveness of a shortened course of MgSO4 postpartally to the standard regimen in prevention of postpartal fits was done.
The study was applied on 40 cases of eclamptic mothers divided in two groups A and B in which A received standard regimen and B received shortened regimen. Study was performed at Elshatby Maternity university hospital after approval of the ethics committee and signing the consent to be involved in this study. All the cases presented with history of preeclamptic toxemia or history of hypertension newly diagnosed in pregnancy came with eclamptic fits were included. Cases with history of recent epileptic fits, drug toxicity and chronic neurologic or psychological disease were excluded.
Patients were divided into two groups, A and B.
In the group A, with standard course, MgSO4 loading dose of 4 g is given IV followed by 5 g IV every 4 hours as maintenance dose for 24 hours postpartally.
In the group B, the loading dose is the same but the maintenance dose was limited to two doses of 5 g MgSO4 given IV with 4 hours intervals postpartally or after the last eclamptic seizures.
In both regimens, 2 gm of MgSO4 was given IV in cases of recurrence fit.
Statistical analysis was done on 40 cases of eclamptic mothers divided in two groups A and B in which A received standard regimen and B received shortened regimen.
The recurrence of fits was not significantly different among the two groups (p = 0.229). In group B, we found a significant reduction in the whole dose of MgSO4.
The fits recurrence, occurred in 15% in the MgSO4 short course group which was not significantly different from the 10% fits recurrence in the standard regimen group.
According to fits about 40% presented antepartum and 45% postpartum and the remaining (15%) presented intrapartum the reduction in dose of MgSO4 in group B as short course MgSO4, the total dose of MgSO4 required was reduced to 14 g in 42.5% of the patients. This is more than 40% reduction in the whole dose of MgSO4 of 34 - 38 g required in 60% of the patients in the standard regimen.
Maternal outcomes were similar in the two groups as they have been followed for 6 weeks postpartally till they came for contraception counselling. The short course regimen got the benefit of low cost and less chance of drug toxicity without compromising quality of care (
In our study, by reducing the duration of magnesium sulfate infusion, we have
| Fits | Group A (n = 20) | Group B (n = 20) | χ2 | P | ||
|---|---|---|---|---|---|---|
| No. | % | No. | % | |||
| Type | ||||||
| Antepartum | 8 | 40.0 | 10 | 50.0 | 0.576 | MCp = 0.829 |
| Intrapartum | 3 | 15.0 | 2 | 10.0 | ||
| Postpartum | 9 | 45.0 | 8 | 40.0 | ||
| Number | ||||||
| 1 | 15 | 75.0 | 16 | 80.0 | 0.143 | FEp = 1.000 |
| 2 | 5 | 25.0 | 4 | 20.0 | ||
| Recurrence | ||||||
| No | 18 | 90.0 | 17 | 85.0 | 0.229 | FEp = 1.000 |
| Yes | 2 | 10.0 | 3 | 15.0 | ||
χ2, p: χ2 and p values for Chi square test for comparing between the two groups.
| Group A (n = 20) | Group B (n = 20) | Test of Sig. | P | |||
|---|---|---|---|---|---|---|
| No. | % | No. | % | |||
| Dose of mg sulphate (gm) | ||||||
| 14 - 34 | 18 | 90.0 | 20 | 100.0 | χ2 = 2.105 | FEp = 0.487 |
| >34 | 2 | 10.0 | 0 | 0.0 | ||
| Min. - Max. | 34.0 - 38.0 | 14.0 - 18.0 | t = 53.774* | <0.001* | ||
| Mean ± SD. | 34.30 ± 0.98 | 14.60 ± 1.31 | ||||
| Median | 34.0 | 14.0 | ||||
χ2, p: χ2 and p values for Chi square test for comparing between the two groups; FE: Fisher Exact for Chi square test for comparing between group A and B; t, p: t and p values for Student t-test for comparing between the two groups; *: Statistically significant at p ≤ 0.05.
achieved reduction in the MgSO4 whole dose, thereby safeguarding the patients against the untoward effects of MgSO4 toxicity.
About 40% presented antepartum and 45% postpartum and the remaining few (15%) presented intrapartum, compared with Nigerian study done by Ado D. Geidamet al., [
This comparative study supported that the short course MgSO4 is as effective as the standard regimen in the treatment of eclampsia.
This was explained by recurrence fits rate between two groups is nearly similar with using short course of MgSO4 as the same findings of Nigerian study done by Ado D. Geidam et al., [
MgSO4 short protocol treatment of eclamptic fits is as effective as the standard protocol of MgSO4 treatment.
The authors are thankful to the Obstetrics and Gynecology Department, Faculty of Medicine, Alexandria University.
All Institutional and National Guidelines for the care and use of animals (insects) were followed.
DE designed the study and performed data collection and analysis. MR interpreted and supervised the Lab analysis results. NE and NH supervised the clinical examinations and US findings. DE wrote the manuscript. All authors were involved in the revision of the manuscript.
The authors declare no conflicts of interest regarding the publication of this paper.
Hefila, N.M. and Abdeldayem, T.M. (2021) Comparative Study between Shortened versus Standard Protocols of Postpartum Magnesium Sulphate Regimen in the Treatment of Eclampsia. Open Journal of Obstetrics and Gynecology, 11, 935-939. https://doi.org/10.4236/ojog.2021.118089